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INTRODUCTION: Discodermolide (1) is a tubulin-binding drug that shows outstanding antitumor properties in cells. 1 Despite the difficulties associated with obtaining it from the natural source (Discodermia dissoluta, a deep-sea sponge that is harvested by a manned submersible) and the length of pioneering total syntheses based on Roche ester (2), discodermolide generated great interest as a potential pharmaceutical because it was active at submicromolar levels, stimulated minimal multi-drug resistance (mdr), and exhibited synergism with taxol. 2 Consequently, Novartis undertook the heroic task of preparing 60 g of discodermolide by a hybrid scheme that combined the most efficient components of the later Smith and Paterson syntheses. 3 Access to this material enabled Novartis to begin clinical trials in 2002.
BODY: Recognizing that the future of discodermolide in the treatment of cancer would require improved efficiency in the chemical synthesis, we analyzed its structure and proposed a total synthesis (Scheme 1) that featured novel and relatively short approaches to the compounds that we perceived to be the optimum key intermediates. Our proposed preparation of the known stereopentad intermediate 4b was by semi-synthesis from the inexpensive agricultural antibiotic oleandomycin 5. The C-1 to C-14 equivalent 3 was to be derived, by way of alkyne 6, from aldehyde 7 and alkyne 8. Each of these would be available from the stereotriad building blocks 9, viewed as available by catalytic asymmetric synthesis. In addition to transformations that had good precedent, our highly convergent plan required less obvious chemistry: the development of an efficient degradation of oleandomycin and the semi-reduction of a propargyl alcohol or ether in the presence of a vinyl iodide. 
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The first major achievement of this project was the demonstration that appropriately protected syn, anti stereotriad building blocks for discodermolide and related polyketide antibiotics could be obtained from variations on a short, scalable scheme that did not rely on Roche ester as a starting material. This practical advance is summarized in Scheme 2 (reported with full experimental details in reference 4, 4 see Appendix). A "spin-off" of this work was the preparation of anti, anti stereotriad building blocks (reported with full experimental details in reference 5, 5 see Appendix). The utility of the new building blocks was then showcased by the preparation of the C-1 to C-14 stretch of discodermolide. This demonstration of the practicality of the catalytic asymmetric approach to the stereotriad is shown in Scheme 3 (reported with full experimental details in reference 6, 6 see Appendix). The original, unorthodox approach to the stereopentad building block of discodermolide by semi-synthesis from oleandomycin was demonstrated as shown in Scheme 4 (reported with full experimental details in reference 7, 7 see Appendix). This scheme represents the culmination of a series of modifications of oleandomycin and its degradation products and offers some unprecedented chemistry: direct cleavage of the aminoglycoside substituent in one step, isomerization of the exocyclic double bond in deoxyoleandomycin to an endocyclic position, and the selective protection of two of three hydroxyl groups in a modified oleandolide. Focusing on the improvement of the synthesis of the C-1 to C-14 stretch, we recognized that the preparation could be made optimally convergent only if it were possible to utilize an iodoolefin substituted alkyne (8) in the convergent step. Furthermore, the efficient synthesis of a (Z)-iodoolefinic building block by methodology not relying on the low-yielding Stork Zhao reaction would facilitate this goal. Therefore we proceeded to examine two transformations essential for the optimization of the preparation of major building block 3.
As an alternative to the Stork Zhao introduction of a vinyl iodide, we considered the iododesilylation of dihydrooxasiline precursors to alkyne 8. We were able to prepare the required dihydrooxasilines in an unprecedented and very convenient procedure by relay metathesis with the Grubbs II catalyst. We were able to carry out the iododesilylation of these substrates with retention of geometry on the double bond (as is appropriate for elaboration to discodermolide) in nonpolar solvents. This chemistry, in the context of discodermolide synthesis is shown in Scheme 5 (reported with full experimental details in reference 8, 8 see Appendix). In addition, we found that the iododesilylation reaction proceeded with inversion of the geometry of the double bond (as is appropriate for some other polypropionate antibiotics) in polar, aprotic 7 solvents. The potential of this conversion is described with full experimental details in a manuscript that is currently in revision 9 (see Appendix).
In a final demonstration of the feasibility of conversions proposed in the original scheme (i.e. 6 -> 3), we showed that vinyl iodides are stable to hydrogenation conditions that reduce a propargyl alcohol to a cis allylic alcohol. This result is reported with full experimental details in reference 10, 10 see Appendix.
The ability to effect this conversion in an advanced discodermolide intermediate will allow us to reduce the number of steps in the synthesis by one and to improve the overall yield by eliminating the inherently low-yielding Stork-Zhao step (used in the sequence from 10 to 6).
A completed synthesis of discodermolide based on this progress would be competitive with the most recent syntheses from Smith and Paterson and with the recently reported Ardisson synthesis.
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Nonetheless, continuing work in the synthetic arena, market forces, and a reevaluation of the status of discodermolide as a drug candidate prompt us to modify our plans for the completion of the synthesis.
Our recent attempts to scale up the oleandomycin degradation have been unrewarding. Both the rhodium chloride isomerization/ deglycosylation and the HI-induced hydrolysis of the aminoglycoside are poorly behaved in the hands of a new co-worker. Although we could probably overcome these difficulties, another problem has appeared. Furthermore, we now think that our overall goal should be modified.
Over the past two years; we have found it increasingly expensive to purchase oleandomycin. Although there is precedent for its manufacture on a large scale, the economics of its production may require its wide use as a livestock antibiotic, a market that seems to have disappeared. Therefore, as a purely practical matter, it behooves us to modify our approach to the stereopentad.
Recently the status of discodermolide as a drug candidate has changed. Novartis has revealed the halting of its clinical trial. This decision has been attributed, in review articles, to toxicity at higher doses. At this time, it appears that this drug, which has the potential for many positive therapeutic features and in which so much time, money, and effort have been invested, will not be developed -at least not in the absence of tumor targeting mechanisms. Consequently, we are now considering the modification of our original plan in order to obtain a discodermolide that is functionalized for conjugation to a targeting moiety.
In moving forward toward completion of the synthesis of discodermolide (or a derivative functionalized for conjugation with a targeting moiety), we plan use the most efficient methods available to us; these include reactions from other syntheses as well as from our own sequence. We believe that our stereotriad synthesis is the most practical of those available but that it can still be improved. Therefore we have begun to optimize its synthesis by developing a modified preparation of the chiral allylic alcohol starting material 12. In the new two-step preparation of 12 (Scheme 6), we avoid the need to prepare a vinyllithium reagent and the need to use butyllithium (compare Scheme 2). Rather, a chiral propynylzinc reagent is prepared under neutral conditions. Then, a subsequent hydrogenation supplies the required allylic alcohol. Our experience with this two-step approach suggests that it will be easily scaled up. This is important as the transmetalation of cis-1-bromopropene and the use of butyllithium in the first step of the overall sequence to the stereotriad (our common precursor to the three major building blocks) is scale-limiting.
A plan to complete the synthesis of discodermolide, functionalized appropriately for incorporation in a conjugate that will deliver it to tumor tissue, is the topic of proposal for an Idea Expansion Award, recently submitted to the Department of Defense Breast Cancer Research Program.
KEY RESEARCH ACCOMPLISHMENTS

One-step hydrolysis of desosamine glycoside (of general interest in the field of organic synthesis and medicinal chemistry).  Application of the Corey cis diene protocol in discodermolide synthesis (of general interest in the field of organic synthesis).  Degradation of oleandomycin with introduction of protecting groups appropriate for elaboration to a known discodermolide intermediate.
Completion of the appropriately substituted building block 4b (C-15 to C-24 stretch of discodermolide) in 12 steps  Proof of principle for the conversion of mass-produced macrolides to value-added polyketide structures.  Demonstration that chiral syn, anti stereotriad building blocks may be efficiently accessed from inexpensive starting materials by elaborating a chiral allylic alcohol prepared by asymmetric catalysis. synthesis (of general interest in the field of organic synthesis).  Demonstration that chiral anti, anti stereotriad building blocks can be obtained by a modification of the above method synthesis (of general interest in the field of organic synthesis).  Preparation of the C-1 to C-14 stretch of discodermolide (6) from the syn, anti stereotriad building block in 10 steps.  Discovery that dihydrooxasilines can be prepared by relay metathesis with the commercially available, air-stable Grubbs II catalyst (of general interest in the field of organic synthesis).  Elaboration of the dihydrooxasiline to both (E)-and (Z)-vinyl iodide-containing polypropionate building blocks (of general interest in the field of organic synthesis).  Discovery of conditions that allow the semi-hydrogenation of a propargyl alcohol in the presence of a trisubstituted (Z)-vinyl iodide (of general interest in the field of organic synthesis). The biosynthetic cascades controlled by the type I polyketide synthases produce a large and diverse family of natural products, in which the key structural feature is a long, methyland oxygen-substituted carbon chain. 1 Many of these metabolites are important medicinals, and many more have promising activity.
The construction of the long, multiply substituted chains required for the chemical synthesis of the nonaromatic polyketides is usually based on the iterative lengthening of an acyclic substituted chain and/or the coupling of several appropriately substituted chains. In this context, stereotriadcontaining building blocks 2,3 have found widespread use. The anti, syn stereotriad that appears in antibacterial (e.g., erythromycin, streptovaricin) and antifungal (amphotericin) macrolides has been the subject of the most attention. It appears three times in the structure of the important nonmacrolide (+)-discodermolide (1, Figure 1 ).
(+)-Discodermolide is a marine natural product, isolated in truly meager amounts from the Caribbean sponge Discoderma dissolute. 4 Originally identified in an immunosup- (1) pressant screen, discodermolide was later shown to have antimitotic activity that results from its binding to microtubules. 5 Discodermolide is a particularly attractive drug candidate because it maintains activity against multidrug resistant organisms 6 and because it demonstrates synergism with taxol. 7, 8 Because of the difficulty in obtaining this valuable compound from its deep-sea source, drug development has necessitated its preparation by total synthesis. Among the impressive total syntheses that have been reported, 9 ,10 Schreiber's original synthesis, 11 the "gram-scale" preparation by Smith, 12 and the subsequent "practical" synthesis of Paterson 13 are noteworthy for having supplied materials for biological testing. Proceeding on the premise that discodermolide will indeed become available in substantial amounts, the Novartis group has scaled up a "hybrid" synthesis and, with synthetic material, advanced discodermolide to phase I clinical trials. 14 Retrosynthesis of discodermolide quickly reveals probable disconnects through or adjacent to the 8,9-and 13,14-olefinic bonds. Consequently, the total syntheses of this target have generally relied on strategies in which an anti, syn stereotriadcontaining building block, functionalized on both ends (Figure 2 ), is parlayed into three more advanced intermediates, appropriately extended and/or activated for sequential coupling.
In general, the stereotriad-containing building blocks for discodermolide synthesis have been prepared by variations on the chiral aldol strategy for the chain extension of an aldehyde derived from the Roche ester 3 ( Figure 3 ). For example, Smith's "common precursor" or "CP" 2 was prepared in eight steps from the Roche ester 3. 15 There are two notable exceptions to this rule. In almost simultaneous disclosures, Dias 16 and Day 17 and later the Novartis group 18 have described the use of recoverable auxiliaries (see 6, and co-workers at Kosan prepared this key lactone by chemical modification of a fermentation product (see 7 f 5, Figure 3 ) from a genetically engineered Streptomyces.
23
In this paper, we describe the preparation of key discodermolide intermediates 5 and 9 from the stereotriadcontaining alcohols 8 ( Figure 4 ). Each of these chiral alcohols 8 is readily available by the catalytic asymmetric synthesis of a chiral cis allylic alcohol and then elaboration by the remarkably efficient and totally overlooked "Midland sequence" (methallylation, 2,3-Wittig rearrangement, protection, and hydroboration).
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In 1984, when this efficient chemistry was demonstrated, chiral cis allylic alcohols could be obtained only indirectly. 25, 26 More recently introduced methodology for the catalytic asymmetric synthesis of allylic alcohols in combination with the Midland sequence allows the preparation of stereotriad building blocks 8 in only five steps from inexpensive, commercially available starting materials (Scheme 1). In this work, we used cyclohexanecarboxaldehyde-derived intermediates for convenience in handling.
Thus, treatment of cyclohexanecarboxyaldehyde (10) with the complex prepared from Z-propenylzinc bromide and lithiated (+)-N-methylephedrine, according to Oppolzer's asymmetric addition protocol, 27 afforded the cis allylic alcohol 11 in 82% yield (92% ee). 28 Alkylation of the alcohol 11 gave the doubly allylic ether 12 which, on treatment with the KO t Bu/ n BuLi reagent, underwent the 2,3-Wittig rearrangement to provide alcohol 13 with two chiral centers established. The ratio of the syn/anti diastereomers of this rearrangement product was, as judged by analysis of the 1 H NMR spectrum, 97:3.
29 Silylation and hydroboration provided the key intermediate 8a. Alternatively, MOM alkylation followed by hydroboration gave alcohol 8b. This strategy allows the preparation of these versatile intermediates in high overall yield and high enantiomeric excess without the sacrifice of a chiral starting material or the need to recycle a chiral auxiliary.
Alcohols 8 are versatile stereotriad-containing building blocks. To illustrate the potential of this approach for the practical synthesis of complex polyketides, we have applied it in the synthesis of lactone 5 and of vinyl iodide 9, which are both intermediates in established syntheses of discodermolide.
The TBS monoprotected diol 8a was easily converted to lactone 5 in two steps (Scheme 2). Ozonolysis with dimethyl sulfide workup followed by MnO 2 oxidation of the crude lactol 15 gave lactone 5 directly (recrystallized product, 80% for two steps). The MOM-protected diol 8b has been converted to vinyl iodide 9, an intermediate in Smith's later generation discodermolide syntheses in which it serves as the precursor to the C-9-C-14 moiety.
10a,b Preparation of vinyl iodide 9 from alcohol 8b was achieved in three steps (Scheme 3). Introduction of the PMB group was followed by ozonolysis to give the aldehyde 17. Then, the Stork-Zhao procedure gave the known building block 9.
Thus, chiral syn, anti stereotriad building blocks, useful for the preparation of polypropionate antibiotics, may be efficiently accessed by short schemes from inexpensive starting materials. Asymmetric catalysis replaces the need for the stoichiometric consumption of a chiral starting material or a chiral reagent or the recycling of a chiral auxiliary. Extension of this strategy to the preparation of advanced intermediates for antibiotic synthesis will be described in due course. Acknowledgment. The work described in this communication was supported by the National Institutes of Health (CA-87503), the Army Breast Cancer Initiative (BC 051816), and the National Science Foundation (CHE-0131146, NMR instrumentation).
Note Added after ASAP Publication. Asymmetric Catalysis Route to anti,anti
As new and promising polypropionate antibiotics are discovered in nature, interest in these compounds as biological probes and as potential therapeutics continues to expand. The preparation of polypropionates is a challenge that has been met by the development of a variety of new methodologies. Nonetheless, the complexity of many target structures is such that more efficient syntheses from inexpensive materials are needed.
The anti,anti stereotriad is a noticeable feature of the structures of numerous polyketide antibiotics. Among these are macrolides isolated from aquatic organisms, primarily from marine sponges (e.g., swinholides) but also from sea snails (aplyronines, e.g., aplyronine A, 1a) and fresh water cyanobacteria (scytophycins, e.g., scytophycin C, 1b), 1 that bear a stereochemically rich, N-vinyl formamide-terminated side chain. There is speculation that the compounds isolated from the higher marine organisms are, in fact, the metabolites of cyanobacteria that are symbiotic with the hosts.
2 These marine macrolides alter the dynamics of the actin polymerization/depolymerization process by binding globular (monomeric) actin (G-actin) and by severing filamentous actin (F-actin). Perhaps, at least in part, because their action interferes with cell division, 3 these compounds are highly cytotoxic.
The anti,anti stereotriad is also found in a second class of marine natural products, the callipeltins. These cyclic and acyclic peptides are notable for their unusual amino acid residues as well as for their impressive biological activities. In callipeltins A, C, D (2), and F-L from Callipelta sp. and Latrunculia sp., 4 and in the closely related neamphamide A from Neamphius huxleyi, 5 a (2R,3R,4R)-3-hydroxy-2,4,6-trimethylheptanoic acid moiety acts as an N-terminal "cap" of the peptide chain.
In order to gain easy access to polypropionate-derived natural products, we have focused on the exploitation of the 2,3-Wittig rearrangement. In 2006, we described the stereoselective rearrangement of a methallyl ether of a chiral cis allylic alcohol to produce a syn stereodiad that was subsequently elaborated to syn,anti stereotriad intermediates for a discodermolide synthesis. 6 The corresponding anti stereodiad is not cleanly available by variations of this direct approach; however, an anti stereodiad is available by the Wittig rearrangement of a propargyl ether of a trans allylic alcohol. 7 Therefore we considered the possibility that the anti,anti stereotriad equivalent 3 might be elaborated from propargyl ether 5 by way of the rearrangement product 4.
This approach to the anti,anti stereotriad 3 offered two desirable features. First, the precursor of the Wittig rearrangement substrate, chiral alcohol 6, should be available by an asymmetric addition reaction in which the chiral ligand can be easily recovered. Second, the enantiomeric stereotriad ent-3 should be equally available by applying the same approach in the enantiomeric series.
The practicality of our overall strategy and its utility have now been demonstrated by the facile preparation of Miyashita's "B-2" (7), a building block in the synthesis of scytophycin C (1b); 8,9 aldehyde 8, an intermediate in Paterson's approach to aplyronine A (1a); and the TBSprotected (for use in total synthesis) 3-hydroxy-2,4,6-trimethylheptanoic acid 9 (TBS-Htmha), the "cap" for callipeltins (e.g., 2). Preparation of stereotriad building block 3 was to be based on elaboration of the 2,3-Wittig rearrangement product 4. Synthesis of this key intermediate began (Scheme 2) with the addition of (E)-1-propenylzinc bromide to cyclohexanecarboxaldehyde in the presence of (+)-N-methylephedrine according to the method of Oppolzer.
11 Allylic alcohol 6 was obtained in 81% yield and 90% ee. 12 Alkylation with propargyl bromide afforded ether 5 in 87% yield. Application of standard [2,3]-Wittig rearrangement conditions afforded (E)-propargylic alcohol 4 (93% yield). The ratio of the anti/ syn diastereomers in this rearrangement product was, as judged by integration of the 1 H NMR spectrum, 96:4.
At this point, our plan was to convert alcohol 4 to the key intermediate 3 (R ) Me) by a sequence consisting of carbometallation with a proton quench, O-methylation, and hydroboration (see Scheme 3). Efforts to obtain useful results by applying the Duboudin carbometallation protocol 13 to substrate 4 afforded a low yield of the desired R-adduct 10 along with the -adduct and recovered starting material. In order to develop an efficient conversion of terminal propargyl alcohols to methallyl alcohols, we studied the product distribution of the carbometallation of 1-cyclohexyl-2-propyn-1-ol (Table 1) . 14, 15 Application of the most favorable protocol to substrate 4 resulted in the isolation of an 81% yield of the desired alcohol 10 along with the recovery of some starting material. Methylation and hydroboration gave the desired synthon 3 (R ) Me). Silylation and ozonolysis demonstrated its utility by conversion to the desired "B-2," aldehyde 7.
An advantage of the asymmetric addition-rearrangement approach to stereotriad-containing intermediates is that both enantiomers of key compound 3 are readily available. For the preparation of Paterson's triad 8 or TBS-Htmha (9), it is more efficient to use a synthon derived from ent-10 than one derived from the previously prepared 10. Therefore the five-step asymmetric synthesis was applied in the enantiomeric series (ent-6 f ent-4 f ent-10, as in Schemes 2 and 3).
Both targets 8 and 9 were then prepared (Scheme 4). Conversion of ent-10 to Paterson's triad 8 was accomplished 4 and buffered NaIO 4 provided the aldehyde target 8. 16 For elaboration of ent-10 to the protected hydroxy trimethylheptanoic acid 9, silylation with TBSOTf (f 13b) was followed by benzylation with benzyl trichloroacetimidate to give the fully protected olefin 15b. Ozonolysis provided aldehyde 16 which was subjected to the Wittig reaction. Treatment of the trisubstituted olefin 17 with hydrogen in the presence of palladium on carbon effected both debenzylation and saturation of the double bond. Oxidation of primary alcohol 18 17 gave TBS-Htmha (9). The advantages of this approach to anti,anti stereotriad building blocks are (1) the use of asymmetric catalysis as a source of chirality, (2) the ready availability of catalysts for both chiral series, (3) the functional group pattern in the synthon (3 or ent-3) itself, which allows generation of an aldehyde in one step in high yield, and (4) the relatively robust protocols required for the short scheme that provides synthon 3 or ent-3. More sophisticated applications are being pursued.
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Scheme 4. Preparation of Paterson's Triad 8 and TBS-Htmha 9
Short Synthesis of the C1−C14 Stretch
The real need 1 for an efficient preparation of discodermolide (1), a polyketide marine natural product considered a candidate for use as a drug for the treatment of solid tumors, has sustained interest in its total synthesis. Indeed, research and development accomplishments targeted toward this goal 2 exemplify the remarkable power of the science of organic synthesis at the turn of the 21st century. Of the likely convergent steps for the completion of the C1-C24 carbon backbone, the joining of protected intermediates that contain the C1-C14 stretch and the C15-C24 stretch appears to be optimally convergent. An approach based on this retrosynthetic analysis served as the basis of the Marshall total synthesis. 3 This dissection has also been employed in Panek's total synthesis, 4 in Smith's fourth generation synthesis, 5 and in the very recent Ardisson synthesis. 6 Also, both Cossy 7 and Kiyooka 8 have prepared advanced C1-C13 intermediates in anticipation of similar endgames.
Our own focus for the completion of a fully functionalized carbon chain has also been on the connection between C14 and C15. Our goals therefore have been the efficient syntheses of the two large synthons (2 and 3, 9 Figure 1 ) for use in a late-stage linkage. We have recently reported a synthesis of the alcohol corresponding to iodide 3 (R ) TBS, R′) TES) from the fermentation product oleandomycin.
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We now address the synthesis of vinyl iodide 2 (R ) TBS). For the preparation of key intermediate 2, we initially examined an approach based on the pseudosymmetry of the C1-C13 stretch. 11 Although this early model study has not yet been extended to total synthesis, the further pursuit of the pseudosymmetry strategy 12 highlighted the need for inexpensive and scalable preparations of stereotriad-containing precursors.
A solution to this perceived problem was found in a short scheme based on a catalytic asymmetric addition (4 f 5) 13 and highly stereoselective [2,3]-Wittig rearrangement (6 f 7) and hydroboration reactions (8 f 9). 14 Thus, the building blocks 9a and 9b, protected for incorporation in different regions of the target 2, were prepared as summarized in Scheme 1. 15 With an inexpensive source of stereotriad-containing building blocks available to us, we reanalyzed our original approach and adapted it to minimize not only the number of steps but the conversion of material. We now describe the rapid preparation of the C1-C14 piece of (+)-discodermolide, appropriately protected for incorporation in a total synthesis, by a convergent scheme based on the readily available 9a and 9b.
As our sequence for the preparation of key intermediate 2 would rely on the highly stereoselective but low-yielding Stork-Zhao reaction, we initially considered approaches in which the iodoolefination transformation was employed prior to the convergent acetylide-addition step (see Figure 2) . However, we noted the reported incompatibility of the C13-14 trisubstituted iodo olefin moiety with introduction of a cis C8-9 olefin by way of reduction of the corresponding acetylene. 4 Therefore, in this, our first attempt to prepare the C1-C14 stretch of discodermolide, we chose to elaborate the iodo olefin late in the preparation of 2 and settled on aldehyde 10 as its immediate precursor. We imagined this compound to be derived from the acetylide-addition product 11, which would be derived from the two stereotriad-containing building blocks 12 and 13. Each of these would be obtained from one of the monoprotected diols 9.
Synthesis of the protected lactal aldehyde 12 is outlined in Scheme 2. Oxidation of the TBS-protected stereotriadcontaining alcohol 9a with TPAP/NMO 16 gave aldehyde 14 in 96% yield. Brown asymmetric allylation 17 with the reagent prepared from (-)-B-methoxydiisopinocampheylborane under the "salt-free" conditions afforded a mixture of alcohols in which one stereoisomer was clearly predominate. Simple silica gel flash chromatography separated the major isomer 15 (71% yield) from the minor isomer (17% yield).
On the basis of extensive precedent, we had predicted that the major stereoisomer from this addition would be the syn, anti, anti stereoisomer 15. 18 This assignment was confirmed by applying the acetonide method of Rychnovsky 19 to diols derived from the separated epimeric alcohols (see the Supporting Information). 
Scheme 1. Synthesis of Stereotriad Building Blocks by Asymmetric Catalysis
Cleavage of the two double bonds in diene 15 by ozonolysis accompanied by cyclization gave lactol 16 (a 1:1 mixture of and R anomers as indicated by NMR analysis). This mixture was subjected to silylation to afford the protected hemiacetal 12 as the R anomer in 70% yield after silica gel flash chromatography.
Synthesis of the other coupling partner, acetylene 13, was straightforward (Scheme 3). Subjection of MOM-protected stereotriad-containing alcohol 9b to TPAP/NMO gave aldehyde 17 in 88% yield. Aldehyde 17 was converted to acetylene 13 in one step by the Ohira-Bestmann reagent in 85% yield. 20 With easy access to both intermediates 12 and 13, we carried out the convergent step (Scheme 4). Treatment of acetylene 13 with BuLi at -40°C, followed by addition of aldehyde 12, afforded a separable 3.5:1 mixture of alcohols. The configuration at C7 of the major epimer was assigned as (S) by the "broadened" version 21 of the modified (or advanced) Mosher method; 22 see the Supporting Information for details. The isolated yield of alcohol 11 (R ) TBS) was 64%.
Propargyl alcohol 11 (R ) TBS) was elaborated to the target 2 (R ) TBS) in five steps (Scheme 4). First, the C7 hydroxyl was protected as the MOM ether. Then cleavage of the double bond by O 3 followed by NaBH 4 reductive workup afforded alcohol 18 (78% for two steps). Reduction of the C8-C9 triple bond to the cis olefin by hydrogenation under Lindlar conditions provided (Z)-olefin 19 in excellent yield. TPAP-NMO oxidation gave aldehyde 10 (90% yield) and the Stork-Zhao olefination gave the target C1-C14 equivalent, vinyl iodide 2 (R ) TBS) in 40% yield (Z:E ) 9:1).
The synthesis of the fully functionalized C1-C14 fragment of (+)-discodermolide (compound 2) required 10 steps from the key building blocks 9a and 9b, each of which was prepared by a five-step sequence (Scheme 1) based on asymmetric catalysis and inexpensive, commercially available starting materials. Building blocks 9 are attractive alternatives to stereotriads derived from (R)-(-)-3-hydroxy-2-methylpropionic acid methyl ester (Roche ester). A particularly advantageous example of their use is in the context of the preparation of the C1-C7 equivalent 16 in which both aldehyde and protected aldehyde groups are generated in a single ozonolysis step. Access to the C1-C14 stretch (key intermediate 2) and to the C15-C24 stretch (alcohol corresponding to iodide 3, R ) TBS, R′ ) TES) of discodermolide has now set the stage for us to complete a total synthesis.
Deconstruction−Reconstruction Strategy
The polyketide antibiotics continue to offer a variety of interesting activities, both as potential medicinals and as biochemical tools. For some of these compounds, particularly some of the stereochemically complex marine natural products, study and development have been limited by a lack of material. 1 For example, the interesting antitumor compound discodermolide (1, Figure 1) , originally obtained by the harvesting of a deep sea sponge, became available in quantities sufficient for clinical testing only after considerable effort by synthetic chemists. The synthesis of complex polyketides by linking linear, functionalized carbon chains requires access to smaller building blocks, many of which contain alternating methyl and oxygen substituents. These are almost universally prepared by one or more of the many stereo-and enantioselective variations on the chiral aldol condensation, accompanied by protection steps and adjustment of oxidation state. 3 Analysis of the total number of operations required for the preparation of longer polyketide synthons by repeated application of this procedure prompted us to seek alternative approaches.
We noted the richness of the chiral pool and, in particular, the macrolide antibiotics that are used in human and veterinary medicine. In this paper, we illustrate the potential of a deconstruction-reconstruction strategy for the preparation of difficult to obtain, stereochemically complex synthetic intermediates from these large-scale fermentation products. Recognizing the C15-C21 stretch of discodermolide in the C1-C7 stretch of oleandomycin 4 (2, Figure 1) , we imagined excising a stereopentad-containing fragment and then elaborating it to one of the C15-C24 iodides 3b-d (Figure 2) . Each of these iodides, prepared from the corresponding alcohol, has served as a key intermediate in a successful total synthesis.
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Focusing on alcohol 3e as our target, we realized that we needed to discover methods for two crucial transformations. First, because we considered C7 of oleandomycin as the progenitor of C21 in discodermolide, we viewed the C7-C8 bond of the oleandomycin macrolide as a target for cleavage. Thus, we needed a method for the functionalization of C7. Second, although the C3 and C5 oxygens are differentially protected in the natural product, the carbohydrate ligands are not attractive protecting groups. We wanted to replace each of them individually or to remove them both and protect the exposed hydroxyl groups selectively and appropriately.
A method for functionalizing C7 of the oleandomycin macrocycle was identified during experiments with deoxy oleandomycin (4) (Scheme 1).
6 Treatment with RhCl 3 -H 2 O in ethanol 7 gave the novel oleandomycins 5a and 5b, the latter the result of cleavage of the more labile glycoside bond. Each of these derivatives was isolated as a clean compound. Given the ability to effect the desired olefin isomerization and to remove the more labile oleandrose substituent, 8 we investigated methods of removing the desosamine ligand. After examination of literature methods 9 and lengthy experimentation, we discovered that treatment of oleandomycin with 55% HI in a two-phase system for 4 h not only opened (4) Oleandomycin can be purchased in gram quantities most readily as its phosphate salt. Larger quantities may be obtained from Biovet JSC.
(5) (a) In their early and elegant total synthesis of discodermolide, Marshall and co-workers coupled iodides 3a and 3b, derived from the corresponding alcohols, with a complex iodo olefin that represented the C1-C14 stretch of discodermolide. They reported an inability to selectively deprotect the C19 hydroxyl group in advanced intermediates derived from the TBS ether 3a and completed the synthesis with intermediates derived from the TES ether 
This one-step procedure for cleaving desosamine from a macrolide conjugate is a considerable improvement over other protocols. The resulting rapid access to the globally deprotected macrolide committed us to a strategy based on selective protection of the hydroxyl groups of a fully deglycosylated intermediate.
Conversion of iodohydrin 6 to the desirable enone 9 was accomplished by adapting known and newly established chemistry to the aglycon system. Thus, treatment with NaHCO 3 afforded the known oleandolide 7 10 and deoxygenation of the epoxide by the method of Sciavolino 6 provided enone 8.
11 Application of the RhCl 3 isomerization procedure then afforded the key intermediate enone 9.
At this point, we sought a method for the selective protection of the C3 and C5 hydroxyl groups. Treatment of triol 9 with 2 equiv of TESOTf proved to be an efficient solution to this problem, providing di-TES ether 10. 12 Silylation of this material with TBDMSOTf gave the tris silyl ether 11. The protecting group pattern in this compound corresponds to that required for elaboration to the known target 3e.
Dissection of the macrocycle was accomplished by a three step sequence. DIBAL-H reduction of both the ketone and lactone groups gave triol 12 which was converted to the corresponding tribenzoate 13. Ozonolytic cleavage of the olefinic bond then gave two products, ketone 14 and aldehyde 15, which were readily separated by chromatography.
Completion of the synthesis of the C15-C24 synthon then required only the elaboration of the terminal cis diene. Efforts to introduce this moiety by direct methods, previously employed for this purpose in what appeared to be similar systems, were disappointing. 13, 14 Success was achieved by employing the dimethylaminopropyl Wittig reagent and subjecting the product to Cope elimination (15 f 16) . This procedure is touted by Corey 15 for the preparation of cis dienes from hindered aldehydes. Cleavage of benzoate 16 with DIBAL-H afforded alcohol 3e (Scheme 3).
The preparation of alcohol 3e in 12 steps and approximately 7% overall yield from oleandomycin demon-(10) Oleandolide (7) was first prepared by a nine-step degradation of oleandomycin; see: Tatsuta, K.; Kobayashi, Y.; Gunji, H.; Masuda, H. Tetrahedron Lett. 1988, 29, 3975. (11) Like iodohydrin 6, enone 8, on standing, converted to material that exhibited two spots on TLC. Therefore, it was used in the next step immediately after isolation.
(12) The regioselectivity of this reaction was established by analysis of the COSY spectrum of the benzoate of the product; see the Supporting Information. strates proof-of-principle for the conversion of massproduced macrolides to value-added polyketide structures. The possibility that ketone 14 might serve as a precursor of a stereotriad or stereotetrad building block for discodermolide or another precious antibiotic has not escaped our attention.
Iodo olefins are important intermediates in organic synthesis. As key reactants in the convergent steps of many total syntheses, they are often the reagents of choice in Heck, Stille and Suzuki, Sonogashira, and Negishi coupling methods 1 as well as in the popular Nozaki-Hiyama-Kishi (NHK) addition reaction.
2 Stereochemical homogeneity in the products of these transformations depends on the availability of geometrically clean iodo olefins as starting materials.
We have been interested in the preparation of a 2-iodo (Z)-olefin of general structure 1 (Figure 1 ) and, in particular, the iodoolefinic alkyne 2, 3 which we projected as a key intermediate in the synthesis of discodermolide (3). 4 Given the small number of approaches to vinyl iodides of this substitution pattern, 5 we considered the design of a new method that might be high yielding and that would be easy to implement. We were especially motivated to prepare alcohol 4, an obvious precursor to alkyne 2 and a generally useful intermediate, from a precursor of general structure 5. Alcohols 5 are readily available from a short scheme based on asymmetric catalysis. 6 Thus, we considered the possibility that the dihydrooxasiline 6 might serve as an intermediate in the desired conversion.
Imagining the silyl ether 6 to be the product of a ringclosing metathesis (RCM) reaction, we set out to attempt this cyclization. 7 Silylation of the known alcohol 5 (R, R ) (CH 2 ) 5 , Scheme 2) with isopropenyldimethylsilyl chloride provided the desired 7. In this metathesis substrate, the functional group pattern should allow RCM to favor the formation of a 6-membered ring containing a trisubstituted olefin (not a cyclobutane and not a 5-membered ring containing a tetrasubstituted olefin). 8 Attempted RCM with Grubbs's second-generation catalyst (8) or with Schrock's catalyst 9 resulted in the recovery of starting material. We repeated both the Grubbs II and Schrock experiments under an atmosphere of ethylene, 9 recovering silyl ether 7 in both cases.
In order to find conditions that would effect the desired closure, we prepared the model substrate 10 and subjected it to metathesis conditions (Scheme 3). Material recovered from the Grubbs II reaction showed two spots on tlc, one of which represented the starting material 10 and the other a new compound(s), which was clearly not the cyclized 11.
10
This result was not particularly surprising. The literature sports no examples of ruthenium catalyst-promoted ring closing olefin metathesis to 1,2-dihydrooxasilines; both Grubbs generation I catalyst 11 and Grubbs generation II catalyst (8) 11c are reported to fail with the relevant substrates. 12 On the other hand, the Schrock catalyst converted silyl ether 10 to the RCM product in 97% yield. (10) The NMR spectrum of the compound represented by the second spot (approximately 10% of the recovered material) contained absorptions in the silylmethyl, vinylmethyl, allyl, vinyl, and aromatic regions (as does silyl ether 10); however, the integral of the aromatic region was enhanced. Metathesis of the catalyst with the substrate is the likely origin of this minor product.
( All of the above suggested that the Grubbs II catalyst would not effect RCM to dihydrooxasilines (as is believed), that the Schrock catalyst would effect such a closure, but that the Schrock catalyst was not generating the critical metal carbene by metathesis with our substrate 7, even when the reaction was run under ethylene.
In an effort to drive the initiation of the metathesis reaction, we resolved to prepare substrate 17, designed so that it would participate in a Hoye-type "relay." 13 In our design, the tether between the initiating terminal olefin and the site of desired reactivity was to be three carbons long, setting up a cascade in which the first ring formed would be a cyclopentene. Also, the tether would contain, adjacent to the internal olefin, two methyl substituents. This design would promote ring closure in the first step of the metathesis reaction by the famous "gem dimethyl effect." 14 Furthermore, substitution at this position would be advantageous in the synthesis of the substrate precursor 16, the product of a 2,3-Wittig rearrangement, 6 by favoring the syn relationship of the adjacent methyl and hydroxyl substituents.
Synthesis of the "relay substrate" 17 relied on methods already established. Preparation of aldehyde 13, which would supply the excisable tether, followed the strategy of Ashby 15 (see the Supporting Information for details). Addition of the chiral zinc reagent 16 from cis-1-bromopropene 17 and (-)-N-methylephedrate afforded the (S)-alcohol 14, which was converted to the methallyl ether 15. Treatment with the n-BuLi/KO-t-Bu reagent effected the expected stereoselective 2,3-Wittig rearrangement. Silylation of the resulting (3S,4S)-undecatrienol 16 afforded the relay metathesis susbstrate 17.
When exposed to the Grubbs II catalyst 8, silyl ether 17 underwent the relay RCM (RRCM) reaction to provide the desired cyclic silyl ether 6 in high yield. The surprising but welcome success of this reaction provides another example 18 of the power of the relay metathesis strategy.
With 6 in hand, we studied methods for effecting the desired conversion to a linear vinyl iodide such as our target 4 (Scheme 5). Ring cleavage of silyl ether 6 with methyllithium 19 proved to be a high yield transformation, giving vinyl silane 18. Then protection of the alcohol (18 f 19) and hydroboration with 9-BBN gave silane 20. 20 Iododesilylation of silane 20 with recrystallized NIS in CH 3 CN/ CCl 3 CN 21 gave a high yield of the known alcohol 4 as an 85:15 Z/E mixture.
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A small amount of a byproduct was also isolated. The NMR spectrum of this compound showed the MOM and TMS groups but no vinyl proton and its infrared spectrum showed no absorption for a hydroxyl group.
We attempted to improve the ratio of isomers in the iododesilylation product of alcohol 20 by adopting hexafluoro isopropanol (HFIP) as solvent. 23 This experiment afforded a crude product, which contained many compounds (as indicated by tlc). Only minor amounts of the desired vinyl iodide 4 (both E and Z, as judged by analysis of the NMR spectrum) could be seen; furthermore, the aforementioned byproduct appeared to be the major component of the product mixture. We suspect that this byproduct results from an iodoetherification reaction and that the use of HFIP in iododesilylations may be limited to substrates that cannot take part in this type of pathway.
24
Improved results were obtained when TBS ether 21 was subjected to the iododesilylation conditions in HFIP. This reaction afforded an 88% yield of the known vinyl iodide 22 (a key intermediate in Smith's fourth-generation discodermolide synthesis) 22 as a 92:8 mixture of (Z)-and (E)-isomers.
Overall, the preparation depicted in Schemes 4-6 provides the original target, iodo olefin 4, in 29% yield (corrected for the presence of the E-isomer) and the vinyl iodide building block 22 in 27% yield (likewise corrected for the presence of E-isomer) from alcohol 12. Thus, the relay RCM preparation of dihydrooxasilines followed by ring opening and iododesilylation provides efficient access to (Z)-vinyl iodides. As it is generally accepted that the Schrock catalyst is required for the closure of vinyl silane metathesis substrates, the effectiveness of the Grubbs II catalyst in the relay RCM reaction (17 f 6) is noteworthy and will be the subject of further examination.
for polypropionate antibiotics that contain trisubstituted (E)-olefins. For example, a syn, anti (E)-isomer of iodide 2 is considered a building block for khafrefungin (4) 5 and the anti, anti (E)-isomer is a potential building block for tyrandamycin A (5, 6 see Figure 1 ). Complex intermediates that contain trisubstituted (E)-olefins adjacent to a series of asymmetric centers are most often prepared from methyl acetylenes by hydrozirconation / iodination 7 or hydrostannylation / iodination. 8 They have also been prepared from (E)-vinyl silanes by iododesilyation with retention of geometry. We noted that iododesilylation in some solvent systems gives appreciable amounts of vinyl iodides in which the geometry of the double bond has not been retained. 2, 3, 9 We imagined that we might find conditions that would lead from the protected homoallylic alcohol substrates 1, which are readily accessible from dihydrooxasilines 6, 4 to the desired vinyl iodides (E)-2 with complete inversion of the geometry of the double bond (Scheme 2). 10 We now describe the results of this venture and, also, the extension of the iododesilylation methodology directly to dihydrooxasiline substrates. We first examined the chemistry of interest in the model homoallylic system 10. Vinyl silanes 10 were easily prepared in 5-6 steps (Scheme 3).
Epoxidation of vinylcyclohexane (7) followed by ring opening with lithiated n-heptyne gave homopropargyl alcohol 8.
11 Functionalization of alcohol 8 with tetramethyldisilazane (TMDS) and intramolecular hydrosilyation catalyzed by the cationic ruthenium complex,
[Cp*Ru(MeCN) 3 ]PF 6 12 provided the dihydrooxasiline 9. Ring cleavage with methyllithium yielded the desired hydroxy vinyl silane 10a. Derivatization gave additional substrates 10b, 10c, and 10d for our studies. Iododesilylation of 10a-d with NIS was studied in three solvent media (Table 1 ). In HFIP containing lutidine, alcohol 10a gave a mixture of products that contained only a small amount of the expected (Z)-vinyl iodide. 4 On the other hand, iododesilylation of substrates 10b and 10c in HFIP with lutidine gave good yields of vinyl iodides (Z)-11b and (Z)-11c, respectively, as the almost exclusive products. These results are consistent with the known propensity of HFIP to favor iododesilylation with high levels of retention of geometry. However, reaction of acetate 10d gave a 5:95 mixture of (Z)-and (E)-vinyl iodides (Z)-11d and (E)-11d. This example suggests that the homoallylic ester substituent participates in the reaction, adding to the iodonium ion and then eliminating anti to the TMS group to provide the (E)-geometry. 13 This pathway is not entirely surprising; 2, 3 however the high level of inverted geometry is impressive and clearly useful. In a 4:1 mixture of MeCN/ClCH 2 CN, iododesilylation of 10a-c gave product mixtures in which the (Z)-olefins predominated. However, an increase in the amount of the (E)-isomer was apparent for the reactions of 10b and 10c. Homoallylic acetate 10d, under these conditions, again gave almost exclusively the (E)-olefin. 
